Psycho Crack

Psycho Crack

Buy Psycho Crack

5 seeds
35.00€
Product sold out
add_alert
  • Free gift
    with every purchase
  • Secure
    payment
  • Discreet
    shipping
  • Free
    shipping (*)

SickMeds and Alchimia Grow Shop present the Psycho Crack variety, created by combining cannabis genetics from the UK and the USA.

It is a hybrid between the Exodus Psychosis and the Green Crack marijuana , two euphoric strains that develop lots of branches, fir-shaped like many tropical Sativas and with woody stems and hard nodes.

It takes around 55-65 days to fully ripen, what is excellent for a 70% Sativa hybrid. It yields up to 500gr/m2 of very smelly buds.

Best results have been achieved with the SCROG technique , although other pruning and molding techniques are also suitable for this plant.

The smell and taste are sweet and fruity with pungent undertones from the Cheese, a very long lasting and flavourful mix.

The effect is similar to Psychosis, with an intense relaxation and mind clouding feeling. Not recommended as daily smoke, it completely breaks your concentration.

Psycho Crack from SickMeds features:

  • Genetics: Exodus Psychosis x Green Crack
  • Type: Feminised seeds
  • 70% Sativa - 30% Indica hybrid
  • Indoor flowering: 55-65 days
  • Indoor yield: 500gr/m2
  • Outdoor harvest: early October
  • THC: 19,2%
  • THCV: 0,4%
  • CBD: 0,1%
  • CBG: 1,2%
  • CBN: 0,0%
  • CBC: 0,9%

Opinions about Psycho Crack and questions

Do you want to give your opinion on Psycho Crack or ask a question about this product?

Watch out, it will be published!

Make sure that it is a valid email address. It will not be published

ATTENTION!! Queries about shipping and payment

For doubts relating to deliveries and payments you can check the sections shipping cost and payment methods.

Today we recommend you...

Seed selector

Subscribe

Do you want to get email notifications about our latest offers and news?

error_outline Use of cookies
We use own and third-party cookies to improve the browsing experience and to offer contents of interest. By continuing navigation we understand that you accept our cookies policy.

keyboard_arrow_up